Extended Data Fig. 4: Methionine restriction inhibits cell proliferation, and most substantially alters cysteine and methionine metabolism in primary colorectal cancer cells.
From: Dietary methionine influences therapy in mouse cancer models and alters human metabolism
a, Relative cell numbers in CRC119 and CRC240 primary tumour cells treated with different doses of methionine for 72 h. Mean ± s.d. n = 3 biologically independent samples; similar results were obtained from 3 independent experiments. *P < 0.05, two-tailed Student’s t-test. b, Volcano plots of metabolites in cells cultured in 0 or 100 μM methionine for 24 h. P values were determined by two-tailed Student’s t-test. c, Left, Venn diagram of significantly changed (*P < 0.05, two-tailed Student’s t-test) metabolites in CRC119 and CRC240 primary cells cultured with no methionine versus control (100 μM methionine), and pathway analysis of metabolites that were commonly changed. Right, fold change of metabolites in cysteine and methionine metabolism, and pyrimidine metabolism, in CRC119 and CRC240 primary cells treated with 0 or 100 μM methionine. Mean ± s.d. n = 3 biologically independent samples. *P < 0.05, two-tailed Student’s t-test. d, Relative fold change of intensity of amino acids by methionine deprivation in CRC119 and CRC240 primary cells. Mean ± s.d. n = 3 biologically independent samples. *P < 0.05, two-tailed Student’s t-test.
